Sfoglia per Autore
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control
2010-01-01 Lanzafame, Massimiliano
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy
2010-01-01 Lattuada, Emanuela; Vallone, A.; Lanzafame, Massimiliano; Corsini, F.; Concia, Ercole; Vento, Sandro
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009.
2011-01-01 Mascarello, M; Gobbi, F; Angheben, A; Gobbo, M; Gaiera, G; Pegoraro, M; Lanzafame, Massimiliano; Buonfrate, D; Concia, Ercole; Bisoffi, Z.
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose.
2012-01-01 Lanzafame, Massimiliano; Lattuada, E; Corsini, F; Concia, Ercole; Vento, S.
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose
2014-01-01 Lanzafame, Massimiliano; Bonora, S; Lattuada, E; Calcagno, A; Di Perri, G; Concia, Ercole
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital
2014-01-01 Costa, E; Biasi, V; Concia, Ercole; Jommi, C; Lattuada, E; Manfr130, S; Venturini, F; Lanzafame, Massimiliano
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up
2014-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Cucchetto, Giulia; Concia, Ercole; Vento, S.
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients
2015-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Rigo, Fabio; Nicole, Stefano; Cucchetto, Giulia; Vento, Sandro
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up
2015-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Rigo, Fabio; Ferrari, Anna; Hill, Andrew; Vento, Sandro
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic
2015-01-01 Lanzafame, Massimiliano; Zorzi, Antonella; Rigo, Fabio; Adami, Irene; DEL BRAVO, Paola; Tonolli, Elisabetta; Concia, Ercole; Azzini, Anna Maria
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction?
2016-01-01 Mazzaferri, Fulvia; Cordioli, Maddalena; Lattuada, Emanuela; Veneri, Dino; Concia, Ercole; Lanzafame, Massimiliano
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load
2016-01-01 Lanzafame, Massimiliano; Gibellini, Davide; Lattuada, Emanuela; Signoretto, Caterina; Mazzi, Romualdo; Concia, Ercole; Vento, Sandro
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings
2017-01-01 Cucchetto, Giulia; Lanzafame, Massimiliano; Nicolè, Stefano; Lattuada, Emanuela; Calza, Leonardo; Concia, Ercole
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature
2017-01-01 Chiesi, Sheila; Piacentini, Daniela; Salerno, NICOLA DUCCIO; Luise, Dora; Peracchi, Marta; Concia, Ercole; Cazzadori, Angelo Antonio; Piovan, Enrico; Lanzafame, Massimiliano
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients
2017-01-01 Rigo, F; Cucchetto, G; Lanzafame, Massimiliano; Nicolè, S; Lattuada, Emanuela; Concia, Ercole; Vento, Sandro
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient
2017-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Nicole', Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports
2017-01-01 Nicole', Stefano; Lanzafame, Massimiliano; Cazzadori, Angelo Antonio; Vincenzi, Marcello; Mangani, Francesca; Colato, Chiara; EL DALATI, Ghassan; Brazzarola, Paolo; Concia, Ercole
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up
2017-01-01 Lanzafame, Massimiliano; Nicole', Stefano; Gibellini, Davide; Lattuada, Emanuela; Cucchetto, Giulia; Rigo, Fabio; Diani, Erica; Concia, Ercole; Vento, Sandro
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life
2018-01-01 Lattuada, Emanuela; Lanzafame, Massimiliano; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials
2018-01-01 Nicole', Stefano; Lanzafame, M; Cucchetto, Giulia; Rigo, F; Lattuada, E; Concia, E
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control | 1-gen-2010 | Lanzafame, Massimiliano | |
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy | 1-gen-2010 | Lattuada, Emanuela; Vallone, A.; Lanzafame, Massimiliano; Corsini, F.; Concia, Ercole; Vento, Sandro | |
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. | 1-gen-2011 | Mascarello, M; Gobbi, F; Angheben, A; Gobbo, M; Gaiera, G; Pegoraro, M; Lanzafame, Massimiliano; Buonfrate, D; Concia, Ercole; Bisoffi, Z. | |
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose. | 1-gen-2012 | Lanzafame, Massimiliano; Lattuada, E; Corsini, F; Concia, Ercole; Vento, S. | |
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose | 1-gen-2014 | Lanzafame, Massimiliano; Bonora, S; Lattuada, E; Calcagno, A; Di Perri, G; Concia, Ercole | |
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital | 1-gen-2014 | Costa, E; Biasi, V; Concia, Ercole; Jommi, C; Lattuada, E; Manfr130, S; Venturini, F; Lanzafame, Massimiliano | |
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up | 1-gen-2014 | Lanzafame, Massimiliano; Lattuada, Emanuela; Cucchetto, Giulia; Concia, Ercole; Vento, S. | |
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients | 1-gen-2015 | Lanzafame, Massimiliano; Lattuada, Emanuela; Rigo, Fabio; Nicole, Stefano; Cucchetto, Giulia; Vento, Sandro | |
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up | 1-gen-2015 | Lanzafame, Massimiliano; Lattuada, Emanuela; Rigo, Fabio; Ferrari, Anna; Hill, Andrew; Vento, Sandro | |
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic | 1-gen-2015 | Lanzafame, Massimiliano; Zorzi, Antonella; Rigo, Fabio; Adami, Irene; DEL BRAVO, Paola; Tonolli, Elisabetta; Concia, Ercole; Azzini, Anna Maria | |
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? | 1-gen-2016 | Mazzaferri, Fulvia; Cordioli, Maddalena; Lattuada, Emanuela; Veneri, Dino; Concia, Ercole; Lanzafame, Massimiliano | |
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load | 1-gen-2016 | Lanzafame, Massimiliano; Gibellini, Davide; Lattuada, Emanuela; Signoretto, Caterina; Mazzi, Romualdo; Concia, Ercole; Vento, Sandro | |
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings | 1-gen-2017 | Cucchetto, Giulia; Lanzafame, Massimiliano; Nicolè, Stefano; Lattuada, Emanuela; Calza, Leonardo; Concia, Ercole | |
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature | 1-gen-2017 | Chiesi, Sheila; Piacentini, Daniela; Salerno, NICOLA DUCCIO; Luise, Dora; Peracchi, Marta; Concia, Ercole; Cazzadori, Angelo Antonio; Piovan, Enrico; Lanzafame, Massimiliano | |
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients | 1-gen-2017 | Rigo, F; Cucchetto, G; Lanzafame, Massimiliano; Nicolè, S; Lattuada, Emanuela; Concia, Ercole; Vento, Sandro | |
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient | 1-gen-2017 | Lanzafame, Massimiliano; Lattuada, Emanuela; Nicole', Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro | |
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports | 1-gen-2017 | Nicole', Stefano; Lanzafame, Massimiliano; Cazzadori, Angelo Antonio; Vincenzi, Marcello; Mangani, Francesca; Colato, Chiara; EL DALATI, Ghassan; Brazzarola, Paolo; Concia, Ercole | |
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up | 1-gen-2017 | Lanzafame, Massimiliano; Nicole', Stefano; Gibellini, Davide; Lattuada, Emanuela; Cucchetto, Giulia; Rigo, Fabio; Diani, Erica; Concia, Ercole; Vento, Sandro | |
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life | 1-gen-2018 | Lattuada, Emanuela; Lanzafame, Massimiliano; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro | |
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials | 1-gen-2018 | Nicole', Stefano; Lanzafame, M; Cucchetto, Giulia; Rigo, F; Lattuada, E; Concia, E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile